ASTHAstrana Health, Inc.
Services-Management Consulting Services
- Revenue
- $3.2B
- 56% YoY
- Operating margin
- 2.5%
- 44% YoY
- EBITDA
- $124M
- 6.0% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- -1.4×
- −$175M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear477% of net incomeCash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowClear29% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear39% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $774M | $1.1B | $1.4B | $2.0B | $3.2B | 56% |
| Operating income | $98M | $104M | $85M | $89M | $79M | 12% |
| Net income | $46M | $46M | $58M | $50M | $24M | 52% |
| Operating cash flow | $70M | $82M | $68M | $52M | $115M | 120% |
| Capex | $19M | $23M | $29M | $8M | $10M | 26% |
| Stock-based comp | $7M | $16M | $22M | $35M | $39M | 12% |
| Buybacks | $6M | $9M | $10M | $900K | $26M | 2744% |
| Dividends | $31M | $14M | $62M | $4M | $8M | 95% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 136 | 148 |
| FY2024 | — | — | 173 | 129 |
| FY2023 | — | — | 210 | 126 |
| FY2022 | — | — | 162 | 124 |
| FY2021 | — | — | 402 | 126 |